---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-24-000077"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2024-06-07T23:59:59+00:00"
generated_at: "2026-06-01T05:27:03.581246+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Lifecore receives Nasdaq delisting notice for missing annual meeting and filing delays

## Summary
- Nasdaq notified Lifecore on June 3, 2024 of non-compliance with listing rules.
- Failure to hold 2023 annual meeting within 12 months of fiscal year-end (May 28, 2023) triggered Rule 5620(a).
- Delays in filing Q1, Q2, and Q3 FY2024 Forms 10-Q violate Rules 5810(c)(2)(G) and 5250(c)(1).
- Company has scheduled 2023 annual meeting for August 15, 2024 and will request extension from Nasdaq Hearings Panel.
- Nasdaq previously granted stay; delisting decision is pending; no immediate effect on stock trading.

## SEC filing metadata
- accession: 0001005286-24-000077
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2024-06-07T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000077/0001005286-24-000077-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000077/lndc-20240603.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-24-000077
- JSON: https://secwatch.observer/filing/0001005286-24-000077.json
- Plain text: https://secwatch.observer/filing/0001005286-24-000077.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.